Actions of nimodipine on the serotonergic systems of rat brain

General Pharmacology

Volumn 29, Issue 3, 1997, Pages 415-419

  Gaggi, Renato ^a   Dall'Olio, Rossella ^a   Santangelo, Marlen ^a   Roncada, Paola ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Dept Pub Hlth and Anim Pathol ^*  (Italy)

Author keywords

5 HT(1A) autoreceptor; 8 OHDPAT; Brain serotonergic systems; Dihydropyridine calcium antagonists; Nimodipine; Serotonin precursor and metabolite

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 HYDROXYTRYPTOPHAN; CALCIUM ANTAGONIST; NIMODIPINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

5-HYDROXYTRYPTOPHAN; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CALCIUM CHANNEL BLOCKERS; HYDROXYINDOLEACETIC ACID; MALE; NIMODIPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PRESYNAPTIC; SEROTONIN; SEROTONIN AGONISTS; SYNAPTIC TRANSMISSION; VASODILATOR AGENTS;

EID: 0030820222     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00484-3     Document Type: Article

References (29)

1. Adachi H. and Shoji T. (1986) Characteristics of the inhibition of ligand binding to serotonin receptors in rat brain membranes by verapamil. Jpn. J. Pharmac. 41, 431-435.
2. Bedard P. and Pycock C. J. (1987) "Wet dog" shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacology 16, 663-670.
3. Bongianni F., Carlà V., Moroni F. and Pellegrini-Giampietro D. E. (1986) Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats. Br. J. Pharmac. 88, 561-567.
4. Colado M. I., Lorenzo P. and Martin M. I. (1989) Nifedipine reversal of decreased serotonin metabolite levels during morphine withdrawal. Arch. Int. Pharmacodyn. 298, 61-67.
5. Dubowsky S. L. (1986) Calcium antagonists: a new class of psychiatric drugs? Psychiatr. Ann. 16, 724-728.
6. Fadda F., Gessa G. L., Mosca E. and Stefanini E. (1989) Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain. J. Neural Transm. 75, 195-200.
7. Gaggi R., Chirivì L., Roncada P. and Gianni A. M. (1992a) Effects of nitrendipine and nisoldipine on biogenic amines in discrete areas of rat brain. Gen. Pharmocol. 23, 881-888.
8. Gaggi R., Cont R. and Gianni A. M. (1993) Comparison among the effects of nifedipine, nimodipine and nisoldipine on the brain biogenic amines of normal or haloperidol treated rats. Gen. Pharmac. 24, 1091-1096.
9. Gaggi R., Dall'Olio R. and Roncada P. (1996) Effects of selective 5-HT receptor agonists 8-OHDPAT and DOI on behavior and brain biogenic amines of rats. Gen. Pharmac. (in press).
10. Gaggi R., Dall'Olio R., Roncada P. and Gianni A. M. (1995) Effects of isradipine and darodipine on serotonergic system of the rat brain. Pharmac. Biochem. Behav. 51, 183-187.
11. Gaggi R., De Iasio R. and Gianni A. M. (1989) Relationships between the effects of peripherally administered salmon calcitonin on calcaemia and brain biogenic amines. Jpn. J. Pharmac. 51, 309-320.
12. Gaggi R. and Gianni A. M. (1990) Effects of calcium antagonists on biogenic amines in discrete brain areas. Eur. J. Pharmacol. 181, 187-197.
13. Gaggi R., Gianni A. M., Chirivì L. and Roncada P. (1992b) Effects of nimodipine on biogenic amines in discrete brain areas. Pharmacology 44, 237-244.
14. Govoni S., Di Giovine S., Moresco R. M., Battaini F. and Trabucchi M. (1988) Effect of chronic calcium antagonist treatment on dopamine recognition sites in rat striatum. Neurosci. Lett. 87, 173-177.
15. 1A receptor agonist 8-OHDPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci. 48, 1779-1786.
16. Hof R. P., Vuorela H. J. and Neumann P. (1982) PY 108-068, a new, potent and selective inhibitor of calcium induced contraction of rabbit aortic rings. J. Cardiovasc. Pharmac. 4, 344-351.
17. Hoffmeister F., Benz V., Heise A., Krause H. P. and Neuser C. (1982) Behavioral effects of nimodipine in animals. Arzneim.-Forsch. Drug Res. 32, 347-360.
18. Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R. and Humphrey, P. P. A. (1994) Seventh International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmac. Rev. 46, 157-203.
19. Itil T. M., Michael S. T., Hoffmeister F., Kunitz A. and Eralp E. (1984) Nimodipine: a calcium antagonist vasodilatator with psychotropic properties (a controlled quantitative pharmaco-EEG study). Curr. Ther. Res. 35, 405-422.
20. Kostowski W., Krzascik P. and Pucilowski O. (1990) Effect of calcium channel inhibitors on D-1 receptor mediated responses: SKF 38393-induced grooming and SCH 23390-induced catalepsy in rats. Biog. Amines 7, 49-56.
21. 3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart. Life Sci. 35, 722-732.
22. Matthews W. D. and Smith C. D. (1990) Pharmacological profile of a model for central serotonin receptor activation. Life Sci. 26, 1397-1403.
23. Miller R. J. (1987) Multiple calcium channels and neuronal function. Science 235, 46-52.
24. 2+ antagonist nimodipine on dopamine metabolism in mouse brain. J. Neural. Transm. 66, 171-187.
25. Pucilowski O. (1992) Psychopharmacological properties of calcium channel inhibitors. Psychopharmacology 109, 12-29.
26. Scriabine A., Schuurman T. and Traber J. (1989) Pharmacological basis for the use of nimodipine in central nervous system disorders. FASEB J. 3, 1799-1806.
27. Seegal R. F., Brosch K. O. and Busch B. (1986) High-performance liquid chromatography of biogenic amines and metabolites in brain, cerebrospinal fluid, urine and plasma. J. Chromatogr. 377, 131-144.
28. 3H]-PN200-110 with calcium channel binding sites in rat brain. J. Neural Transm. 60, 149-167.
29. Zifa E. and Fillion G. (1992) 5-Hydroxytryptamine receptors. Pharmac. Rev. 44, 401-458.